Epidemiology and Etiology of AML

[1]  L. Möllgård,et al.  The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting. , 2020, Blood advances.

[2]  M. Florian,et al.  Understanding intrinsic hematopoietic stem cell aging , 2019, Haematologica.

[3]  Ahmet Zehir,et al.  Oncologic therapy shapes the fitness landscape of clonal hematopoiesis , 2019, bioRxiv.

[4]  G. Juliusson,et al.  Costs per Treatment Phase for AML Patients Receiving High-Dose Chemoterapy in Sweden , 2019, Blood.

[5]  L. Möllgård,et al.  Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period. , 2019, Blood.

[6]  B. Ebert,et al.  Clonal hematopoiesis in human aging and disease , 2019, Science.

[7]  J. Soulier,et al.  Germline DDX41 mutations define a significant entity within adult MDS/AML patients. , 2019, Blood.

[8]  W. Wagner,et al.  Chicken or Egg: Is Clonal Hematopoiesis Primarily Caused by Genetic or Epigenetic Aberrations? , 2019, Front. Genet..

[9]  Jianwei Pan,et al.  The Epidemiological Trend of Acute Myeloid Leukemia in Childhood: a Population-Based Analysis , 2019, Journal of Cancer.

[10]  Xiaomei Ma,et al.  Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. , 2019, Blood reviews.

[11]  O. Visser,et al.  Incidence of acute promyelocytic leukemia across Europe: results of RARECAREnet-a population-based study. , 2019, Stem cell investigation.

[12]  U. Gianelli,et al.  Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options , 2019, International journal of molecular sciences.

[13]  A. Shimamura,et al.  Genetic predisposition to MDS: clinical features and clonal evolution. , 2019, Blood.

[14]  A. Zeidan,et al.  Myeloid disorders after autoimmune disease. , 2019, Best practice & research. Clinical haematology.

[15]  T. Haferlach,et al.  Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML , 2019, International journal of molecular sciences.

[16]  Koichi Takahashi,et al.  Hematologic malignancies and Li–Fraumeni syndrome , 2019, Cold Spring Harbor molecular case studies.

[17]  D. Steensma Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Hematology. American Society of Hematology. Education Program.

[18]  Austin Carter,et al.  Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories , 2018, The Lancet.

[19]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[20]  Paolo Vineis,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[21]  L. Möllgård,et al.  Acute myeloid leukemia in very old patients , 2018, Haematologica.

[22]  M. Nørgaard,et al.  Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population‐based case‐control study , 2018, British journal of haematology.

[23]  C. Fonatsch,et al.  Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders , 2018, Blood Cancer Journal.

[24]  V. Arndt,et al.  Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. , 2018, Cancer Epidemiology.

[25]  L. Shlush Age-related clonal hematopoiesis. , 2018, Blood.

[26]  Juehua Gao,et al.  Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists. , 2018, Archives of pathology & laboratory medicine.

[27]  T. Graubert,et al.  Genomics in childhood acute myeloid leukemia comes of age , 2018, Nature Medicine.

[28]  M. Konopleva,et al.  Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients , 2017, Cancer.

[29]  A. Shimamura,et al.  Genetic predisposition to hematologic malignancies: management and surveillance. , 2017, Blood.

[30]  A. Dueck,et al.  Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia , 2017, JAMA oncology.

[31]  J. Shand Looking up for AML in Down syndrome. , 2017, Blood.

[32]  T. Fioretos,et al.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. , 2017, Blood.

[33]  Anna L. Brown,et al.  Recognition of familial myeloid neoplasia in adults. , 2017, Seminars in hematology.

[34]  M. Höglund,et al.  Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013 , 2017, Leukemia.

[35]  Lars Bullinger,et al.  Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  K. Nichols,et al.  Li‐Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition , 2017, British journal of haematology.

[37]  Erika J. Thompson,et al.  Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.

[38]  B. Ebert,et al.  The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.

[39]  M. Höglund,et al.  Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden , 2016, Leukemia.

[40]  Hans Clevers,et al.  Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.

[41]  Shaoyuan Wang,et al.  Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis , 2016, Hematology.

[42]  J. Lancet,et al.  ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS , 2016, Blood Cancer Journal.

[43]  E. Roman,et al.  Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15 , 2016, Cancer epidemiology.

[44]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[45]  Shaoyuan Wang,et al.  Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis. , 2016 .

[46]  T. Olson,et al.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults , 2016, Leukemia & lymphoma.

[47]  Udit Bhaskar Bhatnagar,et al.  Paclitaxel Induced MDS and AML: A Case Report and Literature Review , 2016, Case reports in oncological medicine.

[48]  Anna L. Brown,et al.  Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies. , 2016, Blood.

[49]  J. Cerhan,et al.  Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. , 2016, Cancer epidemiology.

[50]  A. Tefferi,et al.  Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors , 2015, Blood Cancer Journal.

[51]  J. Gribben,et al.  Disease evolution and outcomes in familial AML with germline CEBPA mutations. , 2015, Blood.

[52]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[53]  David B Richardson,et al.  Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study , 2015, The Lancet. Haematology.

[54]  P. Cin,et al.  Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype , 2015, Leukemia research reports.

[55]  L. Möllgård,et al.  Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia Registry , 2015, American journal of hematology.

[56]  D. Neuberg,et al.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. , 2015, Blood.

[57]  Christopher A. Miller,et al.  The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.

[58]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[59]  D. Link,et al.  Inherited bone marrow failure syndromes in adolescents and young adults , 2014, Annals of medicine.

[60]  H. Ohnishi,et al.  Age is an independent adverse prognostic factor for overall survival in acute myeloid leukemia in Japan , 2014 .

[61]  M. Nørgaard,et al.  Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study , 2014, Leukemia.

[62]  J. Castillo,et al.  The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta‐analysis of epidemiological studies , 2014, American journal of hematology.

[63]  Hong Wang,et al.  Comparison of Toxicity of Benzene Metabolite Hydroquinone in Hematopoietic Stem Cells Derived from Murine Embryonic Yolk Sac and Adult Bone Marrow , 2013, PloS one.

[64]  A. Ogdie,et al.  Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease , 2013, Leukemia & lymphoma.

[65]  R. Snyder Leukemia and Benzene , 2012, International journal of environmental research and public health.

[66]  R. Hehlmann How I treat CML blast crisis. , 2012, Blood.

[67]  A. Niemierko,et al.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  J. Mitri,et al.  Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. , 2012, Leukemia research.

[69]  R. Schlenk,et al.  Therapy-related myeloid neoplasms following treatment with radioiodine , 2012, Haematologica.

[70]  M. Björkholm,et al.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  Frank Lyko,et al.  Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. , 2011, Blood.

[72]  C. Klein Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. , 2011, Annual review of immunology.

[73]  L. Kiemeney,et al.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation , 2011, European Journal of Human Genetics.

[74]  K. Döhner,et al.  The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. , 2011, Blood.

[75]  T. Petrella,et al.  Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Côte d’Or (Burgundy, France) , 2011, Haematologica.

[76]  Y. Assaraf,et al.  High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine. , 2010, Blood.

[77]  M. Schubauer-Berigan,et al.  A meta-analysis of leukaemia risk from protracted exposure to low-dose gamma radiation , 2010, Occupational and Environmental Medicine.

[78]  Philip S Rosenberg,et al.  Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy , 2010, British journal of haematology.

[79]  G. Lyman,et al.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  Patricia A Stewart,et al.  Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. , 2009, Journal of the National Cancer Institute.

[81]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[82]  Sören Lehmann,et al.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. , 2009, Blood.

[83]  K. Chang,et al.  Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  N. Shinton WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[85]  N. Russell,et al.  Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia , 2007, British journal of haematology.

[86]  Soon-Siong Teo,et al.  Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. , 2006, Blood.

[87]  M. Lübbert,et al.  Acute Myeloid Leukemia: Epidemiology and Etiology , 2006, Cancer.

[88]  P. Galvin-Parton,et al.  Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome , 2005, Leukemia & lymphoma.

[89]  J. Reilly Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis? , 2005, British journal of haematology.

[90]  Shinji Yoshinaga,et al.  Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies. , 2004, Radiology.

[91]  S. Cnattingius,et al.  Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[92]  M. Pettenati,et al.  Hematologic malignancies and Klinefelter syndrome. a chance association? , 2002, Cancer genetics and cytogenetics.

[93]  N. Harris,et al.  The World Health Organization (WHO) classification of the myeloid neoplasms. , 2002, Blood.

[94]  James Allan,et al.  Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  C Bos,et al.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. , 2000, Blood.

[96]  D. Neuberg,et al.  Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[98]  J. Pedersen‐Bjergaard,et al.  Two different classes of therapy-related and de-novo acute myeloid leukemia? , 1991, Cancer genetics and cytogenetics.

[99]  R. Larson,et al.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  A. Ciocco,et al.  Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time. , 1966, The New England journal of medicine.

[101]  R. Kostmann Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in Man , 1956 .

[102]  R KOSTMANN,et al.  Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. , 1956, Acta paediatrica. Supplementum.

[103]  G. Klackenberg Studies in Maternal Deprivation in Infants' Homes , 1956, Acta paediatrica.

[104]  D. Lison,et al.  Household exposure to pesticides and risk of leukemia in children and adolescents: Updated systematic review and meta-analysis. , 2019, International journal of hygiene and environmental health.

[105]  T. Graubert,et al.  Chapter 58 – Pathobiology of Acute Myeloid Leukemia , 2018 .

[106]  H. McLeod,et al.  Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. , 2017, The Lancet. Oncology.

[107]  T. Haferlach,et al.  Subtype-specific patterns of molecular mutations in acute myeloid leukemia , 2017, Leukemia.

[108]  Daniel J Weisdorf,et al.  Acute Myeloid Leukemia. , 2015, The New England journal of medicine.

[109]  A. Polednak Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries. , 2014, Journal of registry management.